Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Food Funct ; 5(8): 1866-71, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24943994

RESUMO

A serious complication seen in critically ill patients is the solidification of enteral nutrition causing gastrointestinal obstruction. It has been suggested that enteral nutrition enriched with insoluble fibers may increase the risk of this complication. Therefore, we investigate the effect of soluble and insoluble dietary fibers on the coagulation of a casein-based enteral nutrition in an artificial gastric digestion model. A 100% casein-based enteral nutrition was enriched with increasing concentrations of soluble fibers (acacia fiber, oligofructose and inulin) and insoluble fibers (soy polysaccharide, resistant starch and alpha cellulose). After digestion in an artificial gastric model, the chyme was poured over sequentially placed sieves, separating the coagulate into size fractions of larger than 2 mm, between 1 and 2 mm, and between 0.25 and 1 mm. Of these fractions we measured wet weight, dry weight and protein content. A significant effect on the fraction larger than 2 mm was considered to be clinically relevant. Addition of high concentrations soy polysaccharide and resistant starch to a casein-based enteral nutrition, did not alter the wet weight, whereas dry weight and protein content of the coagulate was significantly reduced. When high concentrations of soy polysaccharide and resistant starch are added to a 100% casein-based enteral nutrition, the coagulate consist of more water and less proteins, which may lead to an increased protein digestion and absorption in a clinical setting. The suggestion that insoluble fibers increase the risk of gastrointestinal obstruction in critically ill patients is not supported by these data.


Assuntos
Caseínas/química , Fibras na Dieta/farmacologia , Digestão , Nutrição Enteral , Modelos Biológicos , Estômago/efeitos dos fármacos , Celulose/farmacologia , Carboidratos da Dieta/farmacologia , Mucosa Gástrica/metabolismo , Conteúdo Gastrointestinal , Inulina/farmacologia
2.
Clin Nutr ; 32(5): 765-71, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23274146

RESUMO

BACKGROUND & AIMS: Non-coagulation of protein from enteral nutrition (EN) in the stomach is considered to improve gastric emptying and may result in reduced upper gastrointestinal complications such as reflux and aspiration pneumonia. For the development of a new EN protein mixture with reduced gastric coagulation, the coagulating properties of individual proteins, a novel blend of four proteins (P4 protein blend) and commercial EN products were investigated. METHODS: A semi-dynamic, computer controlled setup was developed to mimic gastric digestion. The coagulation behaviour of 150 ml protein solutions and EN products was investigated. These were heat-treated calcium caseinate, sodium caseinate, whey, soy and pea protein, and the P4 protein blend comprising of the latter four (all solutions 6% w/v protein), four new enteral nutrition product varieties (New Nutrison® .0 or 1.5 kcal/ml, with and without MultiFibre MF6™) based on the P4 protein blend and two other commercially available casein dominant EN products (T1 and T2). RESULTS: Calcium caseinate and sodium caseinate yielded a total wet coagulate of 43.5 ± 0.7 g and 52.7 ± 6.2 g, respectively. Whey, soy, pea and the P4 protein blend did not produce any measurable coagulate. T1 and T2 resulted in a total wet coagulate of 37.5 ± 0.8 g and 57.3 ± 0.8 g, respectively, while all new EN product varieties based on the P4 protein blend did not produce any measurable coagulate. CONCLUSIONS: The P4 protein blend renders EN product varieties non-coagulating after in vitro gastric digestion.


Assuntos
Digestão , Nutrição Enteral/efeitos adversos , Alimentos Especializados/efeitos adversos , Refluxo Gastroesofágico/prevenção & controle , Modelos Biológicos , Proteínas de Vegetais Comestíveis/metabolismo , Pneumonia Aspirativa/prevenção & controle , Caseínas/efeitos adversos , Caseínas/química , Caseínas/metabolismo , Caseínas/uso terapêutico , Fenômenos Químicos , Fibras na Dieta/efeitos adversos , Fibras na Dieta/metabolismo , Fibras na Dieta/uso terapêutico , Esvaziamento Gástrico , Suco Gástrico/enzimologia , Suco Gástrico/metabolismo , Refluxo Gastroesofágico/etiologia , Conteúdo Gastrointestinal/química , Humanos , Proteínas do Leite/efeitos adversos , Proteínas do Leite/química , Proteínas do Leite/metabolismo , Proteínas do Leite/uso terapêutico , Pisum sativum/química , Proteínas de Vegetais Comestíveis/efeitos adversos , Proteínas de Vegetais Comestíveis/química , Proteínas de Vegetais Comestíveis/uso terapêutico , Pneumonia Aspirativa/etiologia , Desnaturação Proteica , Proteólise , Proteínas de Soja/efeitos adversos , Proteínas de Soja/química , Proteínas de Soja/metabolismo , Proteínas de Soja/uso terapêutico , Estômago , Proteínas do Soro do Leite
3.
Clin Nutr ; 32(4): 556-61, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23219717

RESUMO

BACKGROUND & AIMS: A carbohydrate (CHO) drink given preoperatively changes the fasted state into a fed state. The ESPEN guidelines for perioperative care include preoperative CHO loading and re-establishment of oral feeding as early as possible after surgery. An intestinal ischaemia reperfusion (IR) animal model was used to investigate whether preoperative CHO loading increases spontaneous postoperative food intake, intestinal barrier function and the catabolic response. METHODS: Male Wistar rats (n = 65) were subjected to 16 h fasting with ad libitum water and: A) sham laparotomy (Sham fasted, n = 24); B) intestinal ischaemia (IR fasted, n = 27); and C) intestinal ischaemia with preoperatively access to a CHO drink (IR CHO, n = 14). Spontaneous food intake, intestinal barrier function, insulin sensitivity, intestinal motility and plasma amino acids were measured after surgery. RESULTS: The IR CHO animals started eating significantly earlier and also ate significantly more than the IR fasted animals. Furthermore, preoperative CHO loading improved the intestinal barrier function, functional enterocyte metabolic mass measured by citrulline and reduced muscle protein catabolism, as indicated by normalization of the biomarker 3-methylhistidine. CONCLUSIONS: Preoperative CHO loading improves food intake, preserves the GI function and reduces the catabolic response in an IR animal model. These findings suggest that preoperative CHO loading preserves the intestinal function in order to accelerate recovery and food intake. If this effect is caused by overcoming the fasted state or CHO loading remains unclear.


Assuntos
Carboidratos da Dieta/administração & dosagem , Ingestão de Alimentos/fisiologia , Trato Gastrointestinal/metabolismo , Animais , Biomarcadores/sangue , Glicemia , Citrulina/sangue , Homeostase , Insulina/sangue , Resistência à Insulina , Mucosa Intestinal/metabolismo , Intestinos/patologia , Masculino , Metilistidinas/sangue , Modelos Animais , Período Pós-Operatório , Cuidados Pré-Operatórios/métodos , Ratos , Ratos Wistar , Traumatismo por Reperfusão/patologia , Traumatismo por Reperfusão/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA